What research grade and pharmaceutical grade actually mean

Neither term is a regulatory classification. "Pharmaceutical grade" and "research grade" are commercial descriptions, and no federal regulation in the Code of Federal Regulations defines either one, sets criteria for either one, or assigns either one a purity, identity or documentation requirement. This is checkable rather than a matter of opinion, and the check is quick: a full-text search of the Code of Federal Regulations for the phrase "pharmaceutical grade" on 17 August 2026 returns 14 results, every one of them in Title 40, the Environmental Protection Agency's regulations, where the phrase appears descriptively in analytical methods. The same search for "research grade" returns 16 results, again entirely within Title 40. Restricting either search to Title 21, the food and drug title, returns zero. What the law does instead is define conformance to a published standard, which is a narrower and far more informative kind of claim — and one that most material sold for laboratory research is not making.

Is this just an artefact of how the search works?

No, and the control case is worth running. The phrase "reagent grade" returns 175 results across the CFR, 108 of them in Title 40 and 28 in Title 21. So regulatory drafters do use grade language, and they do use it inside the food and drug title. The absence of "pharmaceutical grade" and "research grade" from Title 21 is a real absence, not a quirk of phrasing or an indexing artefact.

Where "reagent grade" does appear in Title 21, it is used the same way Title 40 uses it — to specify a reagent consumed inside a prescribed test procedure, and usually with an external specification named alongside it. The regulations on food additives and food-contact substances supply the examples: 21 CFR 172.886 calls for "Benzene, A.C.S. reagent grade" and "Acetone, A.C.S. reagent grade" in a test method, and 21 CFR 173.25 for "absolute ethyl alcohol A.C.S. reagent grade" and "A.C.S. reagent grade glacial acetic acid", the initials referring to the American Chemical Society's published reagent specifications. Elsewhere the term appears bare, as in the chloroform and n-heptane called for at 21 CFR 177.1330 and 177.2460.

That is the honest function of grade language: a shorthand pointing at a published specification somebody else maintains, applied to a reagent inside a defined procedure. Used without such a referent, and applied to the product itself rather than to a test reagent, it points at nothing.

What does the law define instead?

Conformance to a compendial monograph. The clearest illustration sits in the compounding provisions of the Federal Food, Drug, and Cosmetic Act, where Congress had to describe acceptable starting material and did so without ever using the word "grade".

Under 21 U.S.C. 353a(b)(1)(A), bulk drug substances used in compounding by a licensed pharmacist or physician must satisfy three conditions together. They must comply with the standards of an applicable United States Pharmacopoeia or National Formulary monograph if a monograph exists — or, where none exists, be components of an approved drug, or appear on a list developed by the Secretary. They must be manufactured by an establishment registered under section 360. And they must be "accompanied by valid certificates of analysis for each bulk drug substance."

Three separate requirements: a published specification, a registered manufacturer, and batch documentation. No adjective does any work in that sentence. That is what a defined standard looks like when a statute writes one down, and it is a useful yardstick to hold any grade claim against.

Two things follow. First, a monograph is a specific document with specific tests and acceptance criteria, so "conforms to the USP monograph for X" is a checkable assertion in a way that "pharmaceutical grade" is not. Second, where no monograph exists for a compound, there is no compendial specification to conform to, and a purity figure is necessarily measured against the testing laboratory's own method rather than a public standard. That is a real limitation on what any certificate for such a compound can mean, and it is not cured by describing the material with a more impressive adjective.

It is worth stating plainly what this section is and is not about. The compounding statute governs the preparation of drug products for identified patients. It does not describe material supplied for in-vitro laboratory research, which is not a drug and is not compounded into one. It is cited here because it is the clearest place in the law where the standard for a starting material is written out, not because it applies to research supply.

Is "Research Use Only" a quality grade?

No. It is a labelling requirement, and it exists in FDA's regulations in one specific context: in-vitro diagnostic products.

Under 21 CFR 809.10(c)(2)(i), a shipment of an in-vitro diagnostic product is exempt from certain labelling requirements where the product is "in the laboratory research phase of development, and not represented as an effective in vitro diagnostic product" and all labelling bears the prominently placed statement: "For Research Use Only. Not for use in diagnostic procedures." A parallel provision covers investigational use.

Read the conditions rather than the phrase. The regulation is about what a product is not being represented as, and about which requirements a shipment is exempt from. It sets no purity specification, requires no testing, and mandates no documentation. A research-use-only designation is therefore a statement of intended use and representation. It carries no information about the quality of what is in the container, and a supplier who presents it as though it did has inverted its meaning.

The regulation is also narrower than the phrase's general circulation suggests, since it governs diagnostic products rather than chemicals generally. There is no parallel provision defining a research-use grade for bulk substances, which is consistent with what the CFR search above found.

So what is actually checkable?

Measurements, attributed and dated. Where a grade claim is an adjective, a measurement is a record that another party can be asked to confirm.

That is the standard our own published certificates are built to meet, and their scope is limited to exactly what was measured. BPC-157 batch 2026-03, GHK-Cu batch 2026-03, Retatrutide batch 2026-03, MOTS-c batch 2026-03 and NAD+ batch 2026-03 each name the compound, the batch, the analytical method, the test date and the third-party laboratory that signed the report, and the certificates carry a verification key checkable directly with that laboratory.

None of those pages asserts monograph conformance, because no such determination was made. None asserts a grade. They report a chromatographic purity determination on a named batch on a stated date, which is a smaller claim than "pharmaceutical grade" and, unlike it, one that can be independently checked.

Veridian Research supplies these materials strictly for in-vitro laboratory research. They are not drugs and are not approved for human or veterinary use.

The short version

"Pharmaceutical grade" and "research grade" are not defined in United States regulation; a CFR full-text search finds both phrases only in EPA rules and neither anywhere in Title 21, while "reagent grade" — which does point at external published specifications — returns twenty-eight Title 21 results. The law's actual mechanism for describing acceptable material is monograph conformance plus a registered manufacturer plus a certificate of analysis, spelled out at 21 U.S.C. 353a(b)(1)(A) for compounding. "Research Use Only" is a labelling statement defined at 21 CFR 809.10(c) for in-vitro diagnostic products and says nothing about purity. When a grade term appears without a named standard behind it, the useful response is to ask which document it refers to, and to read the batch-specific measurement instead.